Etching Reactor for MXene synthesis Tags

Sorry, but nothing matched your search terms. Please try again with some different keywords.

MRC Joins New Horizon Europe BioMIX Project to Develop MXene-Based Therapies for Triple-Negative Breast Cancer
Materials Research Centre (MRC) is proud to announce its participation in BioMIX, a newly funded Horizon Europe MSCA Staff Exchanges project coordinated by the University of Latvia. BioMIX aims to address these challenges through the development of a biomimetic MXene-based nanoplatform based on Ti₃C₂ MXene nanosheets. The proposed platform is designed to combine several therapeutic mechanisms in a single system, including targeted doxorubicin delivery, suppression of the MDR1/P-glycoprotein drug-resistance pathway, and ultrasound-triggered sonodynamic therapy.
Exploring New Opportunities for MXene Applications with AGH University of Krakow
The seminar, titled “MXenes for Space and High-Tech Applications: From Scalable Synthesis to Smart Structures, Sensors, and Advanced Bio-Composites,” brought together researchers interested in the development and application of advanced nanomaterials. The presentation covered recent progress in MXene technology, with a particular focus on scalable synthesis and the integration of MXenes into smart structures, sensors, advanced electronics, multifunctional composites, and space technologies.
Green-Synthesized MXenes Enable Low-Friction, Cytocompatible PVA-Chitosan Hydrogels
The study, “Green-Synthesized MXenes Enable Low-Friction, Cytocompatible PVA-Chitosan Hydrogels,” explores the incorporation of HF-free, green-synthesized Ti₃C₂Tₓ MXenes into polyvinyl alcohol (PVA)-chitosan hydrogels. The research demonstrates that this combination can produce highly hydrated, mechanically enhanced, cytocompatible materials with significantly improved tribological properties.